Nasdaq:US$13.60 (-0.18) | HKEX:HK$21.06 (-0.36) | AIM:£1.97 (-0.03)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Anti-tumour activity of Epitinib in patient derived esophagus cancer models